Meet Our Team
Nicole is a functional geneticist with a rich background in protein engineering, precision medicine, and deep mutational scanning screens.
She holds a Ph.D. in Biophysics from Brandeis University where she studied DNA replication and repair and was a Postdoc at Memorial Sloan Kettering Cancer Center in crystallography.
She subsequently held positions at the Broad Institute of MIT and Harvard as a research scientist in the Cancer Program and Genetic Perturbation Platforms with a focus on Deep Mutational Scanning.
As Director of Functional Genomics at Constantiam Biosciences, Nicole is focused on leveraging massively-multiplexed experiments to improve variant interpretation.
Connect with me
Kirk is a statistical geneticist by training with experience in bioinformatics and computational biology working with various levels of omics data for inferring the architecture of genotype–phenotype maps for complex traits and diseases. He holds a PhD in Biostatistics from the Department of Public Health Sciences at Penn State College of Medicine and was a Postdoc at the Broad Institute of MIT and Harvard. Along with his academic experience, he also brings experience in industry at early stage startups implementing computational methods for large NGS based screens. As Director of Computational Biology at Constantiam Biosciences, Kirk is focusing on developing and implementing robust methods to scale and make human genetic variant discoveries more actionable.
Connect with me
Zainab is a Marketing and Communications Strategist at Constantiam Biosciences. She holds a Bachelor’s degree in Microbiology and Molecular Genetics and a Master’s degree in Public Health. Additionally, she is Meta Certified Creative Strategist and holds a certification in Digital Health by Harvard Business School. With a strong interest in health tech and biotech advertising and marketing, Zainab combines her scientific background with strategic marketing skills. She is dedicated to creating effective marketing strategies that support Constantiam Biosciences’ mission to advance genetic testing and precision medicine.
Connect with me
Nicholas is a biophysicist with expertise in computational and experimental methods. His past academic work focused on several areas of protein biophysics including molecular mechanisms of disease, membrane proteins, misfolding and aggregation, and evolution and design. He holds a Ph.D. in Physics from Rice University, was a Postdoc at Aarhus University, and is a visiting scientist at the Center for Theoretical Biological Physics. As CEO and co-founder of Constantiam Biosciences, Nicholas is focused on improving the state-of-the-art in genetic variant interpretation.
Connect with me
Daniel is a biochemist with broad expertise in the biomedical sciences, including gene therapies, gene editing, RNA biology, and protein folding. He holds a Ph.D. in Chemistry from the University of California, Berkeley, and was a Damon Runyon Cancer Research fellow at The Johns Hopkins University School of Medicine. As CSO and co-founder of Constantiam Biosciences, Daniel is focused on developing core technologies to advance genomic medicine.
Connect with me
As a scientist by training, he has held multiple technology transfer and business development roles in academic, venture, incubator and large corporation settings. He holds a Ph.D. in Nutritional Biochemistry from the University of Minnesota-Twin Cities, and was doctoral dissertation and Larry L. Hillblom Foundation fellow. He is also a certified licensing professional (CLP) and has closed over $90M worth of licenses and service contracts. As chief commercial officer and co-founder of Constantiam Biosciences, Norman is passionate in bringing innovative solutions to make a meaningful healthcare impact.
Connect with me
Advisors
Frederick (Fritz) Roth is a Professor and Chair of the Department of Computational and Systems Biology at the University of Pittsburgh School of Medicine. He is a pioneer in the development and clinical application of massively-multiplexed functional assays and computational variant effect predictors. As Founding Scientific Advisor at Constantiam Biosciences, Fritz works directly with the co-founders on developing technology, setting research goals, and enhancing product offerings.
Connect with me
Eric J. Evans is an experienced life sciences senior executive. After beginning his career in brand management at Procter & Gamble and in strategy consulting at the Boston Consulting Group, he went on to be Managing Director of Growth Analytics LLC, an international consulting firm specializing in early-stage life sciences technologies. He subsequently served as CEO for several biomedical companies, including Targeted Cell Therapies, Abazyme, Lumos Catheter Systems, Mulleris Therapeutics, Follica Biosciences, Primatope Therapeutics and Pykus Therapeutics. Currently he serves as Executive Chairman of Unison Medicines and is assisting NIH (National Institutes of Health) with their RADx (Rapid Acceleration of Diagnostics) initiative. Mr. Evans holds a master’s degree in finance and public policy from the Wharton School at the University of Pennsylvania, and a bachelor’s degree in nuclear physics from Brown University. He holds an appointment as Senior Fellow at the Harvard Kennedy School.
Connect with me
Victoria (Vicki) Parikh is the Director of the Center for Inherited Cardiovascular Disease and an Assistant Professor in the Department of Medicine at Stanford University. As an expert in clinical applications of high-throughput functional assays, her time is divided between the clinic and the laboratory. As Clinical Advisor at Constantiam Biosciences, Vicki works directly with the co-founders to ensure that Constantiam’s product have the maximum positive clinical impact.
Connect with me
Jeanne Morin-Leisk is a trained Clinical Genomic Scientist and experienced Product Manager who has led efforts to develop new products and integrate new technologies for multiple genetic testing companies. As Product Advisor at Constantiam Biosciences, Jeanne works directly with the co-founders to ensure that Constantiam’s product offerings and future product roadmap are aligned with the most acute needs of the industry.
Connect with me
Emil Pedersen is an experienced data scientist and engineering leader who has built four teams from the ground up across multiple industries. He holds a B.S. in Physics and an M.S. in Electrical Engineering from Aarhus University.
Connect with me
Managing Director at FHF Ventures
MBA from the University of Chicago
Decades of experience selling high value data assets in a B2B setting
Experienced advisor to executive teams.
Connect with me
Brian Shirts, M.D., Ph.D.
Clinical Consultant
Brian Shirts, M.D., is a board-certified physician and the assistant director of UW Medicine Genetics and Solid Tumor and Informatics at UW Laboratory Medicine. He earned his M.D. and Ph.D. at the University of Pittsburgh and is board-certified in Clinical Pathology and Molecular Genetic Pathology. Dr. Shirts specializes in genetic testing for hereditary cancer risk and other complex hereditary traits. His clinical and research interests include improving the detection and classification of rare mutations, particularly in familial cancer genes, and the clinical classification of rare genetic variants of uncertain significance.
Connect with me
Interns
Andy is a student majoring in computer science with a primary interest in machine learning and artificial intelligence. He utilizes his passion for these topics in working on Constantiam’s systems which bring understanding to genetic variants. He is currently pursuing a degree at Rice University.
Connect with me